Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,981
Total Claims
$1.7M
Drug Cost
1,282
Beneficiaries
$1,345
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+89%
Opioid rate vs peers
65.7% vs 34.8% avg
+219%
Cost per patient vs peers
$1,345 vs $422 avg
+99%
Brand preference vs peers
9.4% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
65.7%
Opioid Rate
5,900
Opioid Claims
$1.5M
Opioid Cost
14.3%
Long-Acting Rate
This provider's opioid prescribing rate of 65.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 846 claims · $828K
Generic: 8,135 claims · $896K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 408 | $587K |
| Tapentadol Hcl | 176 | $259K |
| Tapentadol Hcl | 170 | $233K |
| Oxycodone Hcl | 150 | $124K |
| Hydrocodone/Acetaminophen | 2,563 | $72K |
| Levorphanol Tartrate | 14 | $50K |
| Oxycodone Myristate | 65 | $44K |
| Oxycodone Hcl | 1,414 | $37K |
| Rimegepant Sulfate | 19 | $28K |
| Lidocaine | 45 | $21K |
| Buprenorphine Hcl | 22 | $19K |
| Buprenorphine Hcl/Naloxone Hcl | 135 | $16K |
| Buprenorphine | 43 | $14K |
| Buprenorphine Hcl/Naloxone Hcl | 15 | $13K |
| Buprenorphine | 11 | $10K |
Prescribing Profile
42
Unique Drugs
21.0
Anomaly Score
Patient Profile
68
Avg Age
63%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About